The U.S. Facilities for Illness Management and Prevention (CDC) and the Meals and Drug Administration (FDA) requested that the Johnson and Johnson vaccine be suspended within the nation due to the weird clotting that occurred in 6 ladies 6 to 13 days after vaccination.
DISTRIBUTION TO EUROPE DELAYED
Following this choice, the US-based pharmaceutical firm Johnson and Johnson (J&J) introduced that it could delay the introduction of the vaccine in Europe.
“WE HAVE TAKEN PRECAUTION AND DECIDED TO DELAY THE DISPLAY OF OUR VACCINE”
In a press release from the corporate, “By taking precautionary measures, now we have determined to delay the unfold of our Kovid-19 vaccine in Europe.” assertion shared.
EU PLACED 200 MILLION ORDERS
Within the assertion, it was said that federal authorities will droop the distribution and utility of the vaccine, whereas it was famous that the CDC Vaccination Practices Advisory Committee will meet tomorrow to focus on the reviews. European regulators authorized the use of the Kovid-19 vaccine produced by Johnson and Johnson on March 11, and for this 12 months, the European Union (EU) ordered 200 million doses, and the UK 30 million doses of vaccine.
THE USE OF ASTRAZENECA VACCINE HAS BEEN DISCONTINUED DUE TO THE SAME REASON
However, in March, Eire, Norway, Denmark, Iceland, Romania, Italy and Bulgaria quickly stopped the use of the Oxford-AstraZeneca vaccine, which is broadly utilized in European international locations, on the grounds that it induced blood clots in some sufferers.
Johnson & Johnson and AstraZeneca vaccines, produced with the identical expertise, use a chilly virus referred to as adenovirus to carry the spike gene that covers the outer floor of Kovid-19 into the physique.
#Johnson #Johnson #delays #distribution #coronavirus #vaccine #Europe
Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.